Choice of injectable opioid treatment may help former inmates stay on track
NCT ID NCT06880718
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot trial tests two long-acting injectable buprenorphine medications (Sublocade and Brixadi) in 60 incarcerated individuals with opioid use disorder who are about to be released from prison. Participants either choose their preferred medication or are randomly assigned one. The study tracks how well they stay in treatment, their opioid use, and their satisfaction over six months after release. The goal is to see if giving people a choice improves treatment retention and outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Buprenorphine (extended-release injectable formulations: Sublocade and Brixadi)
- What this could lead to
- If this trial succeeds, it could show that giving people leaving prison a choice of injectable buprenorphine helps them stay in treatment longer and reduces opioid relapse after release.
- What could go wrong
- This is a small pilot study with only 60 participants, so results may not apply to everyone. It compares two similar drugs, so differences may be small, and long-term effects are not yet known.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BUPRENORPHINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rhode Island Department of Corrections
RECRUITINGCranston, Rhode Island, 02920, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tool better measure opioid withdrawal?
- Giving patients a voice in methadone care: a new approach under the microscope
- Can a sleep pill boost success in opioid treatment?
- Can coaching clinics curb HIV? a new strategy puts it to the test
- Could a trip to the pediatrician help teens beat opioid addiction?
- A nose spray before treatment: could naloxone speed up opioid recovery for fentanyl users?